Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI

Recruiting Phase 4 Interventional Study
Healthy Caffeine Adenosine Dopamine D2/3 Receptor Availability
Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Basic Science
Participants needed
12 (estimated)
Sponsor
Hsiao-Ying Wey · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This research study aims to determine whether and how caffeine intake affects learning process through reward feedback compared to placebo. The data acquired from this study would improve our understanding on the consequence and mechanism of caffeine intake in the aspect of learning process. Participants will perform a reinforcement learning task (i.e. Probabilistic Selection Task) and a motor in…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 and ≤ 45. * Habitual caffeine intake ≥ 100 mg and ≤ 450 mg daily. * Non-smokers. * Clinically healthy. * Have normal vision or corrected to normal vision. Exclusion Criteria: * Pregnant or lactating women. * Women using hormonal contraceptives. * BMI \< 18.5 or \> 2…
Contacts

Hsiao-Ying Wey, PhD

6177241384

hsiaoying.wey@mgh.harvard.edu

CONTACT